The study below was published in the New England Journal of Medicine, entitiled "Two Phase 3 Trials of Baricitinib for Alopecia Areata".
You Might Also Enjoy...
These are the first two CME articles on hair transplantation to ever be published in the leading peer reviewed journal in our field. I am proud to be one of its authors.
During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.
This analysis demonstrates that there is no increased risk of cancer when using spironolactone.
For some highly motivated patients, a combination of two therapies can be effective in helping hair loss.
The New England Journal of Medicine published an interesting article on vaccine effectiveness and the need for boosters.
The attached article from the FDA outlines the medical risks associated with JAK(Janus kinase) inhibitors for the treatment of alopecia totalis and universalis.
